T-knife is a biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies for the treatment of cancer. The Company leverages its off-the-shelf fully human TCRs to manufacture patient-derived T cell products targeting tumor-specific antigens.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.